Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications
Mustafa Arici,Samir Helmy Assaad-Khalil,Marcello Casaccia Bertoluci,Jason Choo,Yau-Jiunn Lee,Magdalena Madero,Guillermo Javier Rosa Diez,Vicente Sánchez Polo,Sungjin Chung,Teerawat Thanachayanont,Carol Pollock,Arici,M.,Assaad-Khalil,S. H.,Bertoluci,M. C.,Choo,J.,Lee,Y.-J.,Madero,M.,Rosa Diez,G. J.,Sanchez Polo,V.,Chung,S.,Thanachayanont,T.,Pollock,C.
DOI: https://doi.org/10.1136/bmjopen-2023-080891
IF: 3.006
2024-03-08
BMJ Open
Abstract:Background Chronic kidney disease (CKD) affects around 10% of the global population and has been estimated to affect around 50% of individuals with type 2 diabetes and 50% of those with heart failure. The guideline-recommended approach is to manage with disease-modifying therapies, but real-world data suggest that prescribing rates do not reflect this in practice. Objective To develop a cross-specialty consensus on optimal management of the patient with CKD using a modified Delphi method. Design An international steering group of experts specialising in internal medicine, endocrinology/diabetology, nephrology and primary care medicine developed 42 statements on aspects of CKD management including identification and screening, risk factors, holistic management, guidelines, cross-specialty alignment and education. Consensus was determined by agreement using an online survey. Participants The survey was distributed to cardiologists, nephrologists, endocrinologists and primary care physicians across 11 countries. Main outcomes and measures The threshold for consensus agreement was established a priori by the steering group at 75%. Stopping criteria were defined as a target of 25 responses from each country (N=275), and a 4-week survey period. Results 274 responses were received in December 2022, 25 responses from Argentina, Australia, Brazil, Guatemala, Mexico, Singapore, South Korea, Taiwan, Thailand, Turkey and 24 responses from Egypt. 53 responses were received from cardiologists, 52 from nephrologists, 55 from endocrinologists and 114 from primary care physicians. 37 statements attained very high agreement (≥90%) and 5 attained high agreement (≥75% and <90%). Strong alignment between roles was seen across the statements, and different levels of experience (2–5 years or 5+ years), some variation was observed between countries. Conclusions There is a high degree of consensus regarding aspects of CKD management among healthcare professionals from 11 countries. Based on these strong levels of agreement, the steering group derived 12 key recommendations focused on diagnosis and management of CKD.
medicine, general & internal